Yüklüyor......
Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks?
Presymptomatic DNA testing for autosomal dominant hereditary breast/ovarian cancer (HBOC) became an option after the identification of the BRCA1 and BRCA2 genes in 1994-1995. Healthy female mutation carriers have a high lifetime risk for breast cancer (56-87%) or ovarian cancer (10-60%) and may opt...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Group
1999
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1734277/ https://ncbi.nlm.nih.gov/pubmed/10593998 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|